Hydrogen Sulfide and Functional Therapy: Novel Mechanisms from Epigenetics
Antioxidants & Redox Signaling · 2024-01 · 40 (1-3) · 110-121
DOI: 10.1089/ars.2023.0425 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 17.01.2024. Verfasst von Qian Ding und 11 weiteren Autor:innen. Beteiligte Einrichtung: University Joint Laboratory of Guangdong Province and Macao Region on Molecular Targets and Intervention of Cardiovascular Diseases, Affiliated Hospi…. Hauptthemen laut MEDLINE: Hydrogen Sulfide, MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 123 Literaturangaben.
Abstract (Originalsprache)
Hydrogen sulfide (H2S) is a gasotransmitter with significant physiological effects, including anti-inflammatory properties, regulation of oxidative stress, and vasodilation, thus regulating body functions. Functional therapy involves using treatments that target the underlying cause of a disease, rather than simply treating symptoms. Epigenetics refers to changes in gene expression that occur through modifications to DNA, to the proteins that package DNA, or to noncoding RNA mechanisms. Recent research advances suggest that H2S may play a role in epigenetic regulation by altering DNA methylation patterns and regulating histone deacetylases, enzymes that modify histone proteins, or modulating microRNA mechanisms. These critical findings suggest that H2S may be a promising molecule for functional therapy in various diseases where epigenetic modifications are dysregulated. We reviewed the relevant research progress in this area, hoping to provide new insights into the epigenetic mechanisms of H2S. Despite the challenges of clinical use of H2S, future research may lead to the progress of new therapeutic approaches. Antioxid. Redox Signal . 40, 110–121.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Joint Laboratory of Guangdong Province and Macao Region on Molecular Targets and Intervention of Cardiovascular Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
- State Key Laboratory of Quality Research in Chinese Medicine and School of Pharmacy, Macau University of Science and Technology, Macau SAR, China.
- School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
- School of Pharmacy, Fujian Medical University, Fuzhou, China.
- Biomedical Science, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
- Shanghai Key Laboratory of Bioactive Small Molecules, Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China.
ORCID-Profile: Yi Zhun Zhu
Zitieren
APA
Ding, Q., Song, W., Zhu, M., Yu, Y., Lin, Z., Hu, W., Cai, J., Zhang, Z., Zhang, H., Zhou, J., Lei, W., & Zhu, Y. Z. (2024). Hydrogen Sulfide and Functional Therapy: Novel Mechanisms from Epigenetics. Antioxidants & Redox Signaling, 40(1-3), 110-121. https://doi.org/10.1089/ars.2023.0425
Vancouver
Ding Q, Song W, Zhu M, Yu Y, Lin Z, Hu W, et al. Hydrogen Sulfide and Functional Therapy: Novel Mechanisms from Epigenetics. Antioxidants & Redox Signaling. 2024;40(1-3):110-121. doi:10.1089/ars.2023.0425
BibTeX
@article{Ding2024,
author = {Ding, Qian and Song, Wu and Zhu, Menglin and Yu, Yue and Lin, Zhongxiao and Hu, Wei and Cai, Jianghong and Zhang, Zhongyi and Zhang, Hao and Zhou, Junyang and Lei, Wei and Zhu, Yi Zhun},
title = {Hydrogen Sulfide and Functional Therapy: Novel Mechanisms from Epigenetics},
journal = {Antioxidants & Redox Signaling},
year = {2024},
volume = {40},
number = {1-3},
pages = {110--121},
doi = {10.1089/ars.2023.0425}
}
EUVIMED